Schedule 13D ownership disclosure

Dermata Therapeutics, Inc.

Common Stock, Par Value $0.0001 Per Share. · CUSIP: 249845108

Event date: 2025-01-21

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • PROEHL GERALD TReported CIK 0001279191

    Shares: 803,751.00 · Class: 16.0%

  • Proehl Investment Ventures LLCReported CIK 0001877913

    Shares: 799,624.00 · Class: 15.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-003484
Form type
SCHEDULE 13D/A
Filer
Dermata Therapeutics, Inc.
CIK
CIK 1853816
Filed
Jan 23, 2025
Reporting period
Jan 21, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub